Clinical Trials on GEN1 genmutation in China
I alt 340 resultater
-
Shandong UniversityFudan University; Chinese Nutrition SocietySuspenderetSund og rask | GEN1 genmutationKina
-
Jiangsu Province Centers for Disease Control and...Bejing Vigoo Biological Co., LTDAfsluttetSystembiologi | Tidlig Gene | EV71-vaccineKina
-
First Affiliated Hospital of Chongqing Medical...Ikke rekrutterer endnuKræft | Positron emissionstomografi | Stimulator af interferon-genKina
-
QED Therapeutics, Inc.Helsinn Healthcare SAAfsluttetFGFR2-genmutation | Avanceret cholangiocarcinomKorea, Republikken, Forenede Stater, Belgien, Spanien, Taiwan, Kina, Det Forenede Kongerige, Frankrig, Canada, Tyskland, Thailand, Italien, Portugal, Australien, Puerto Rico
-
Zhongnan HospitalAktiv, ikke rekrutterendeFarmakokinetisk | Abirateronacetat | Plasma koncentration | Gen polymorfisme | Metabolisk analyseKina
-
Southwest Oncology GroupNational Cancer Institute (NCI)AfsluttetBRCA1 genmutation | BRCA2 genmutation | Tilbagevendende planocellulært lungekarcinom | Stadie IV Planocellulært lungekarcinom AJCC v7 | BRIP1 genmutation | PALB2-genmutation | ATM-genmutation | ATR-genmutation | CHEK2 genmutation | NBN-genmutation | RAD51 genmutation | CHEK1 genmutation | FANCA genmutation | FANCD2 genmutation og andre forholdForenede Stater, Canada
-
Fujian Cancer HospitalUkendt
-
Nanfang Hospital of Southern Medical UniversityRekrutteringForskelligt gen mellem forskellige TKI's effektKina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Eli Lilly and Company; Genentech, Inc.; Kazia... og andre samarbejdspartnereRekrutteringMetastatisk malignt fast neoplasma | Metastatisk malign neoplasma i hjernen | NTRK familie genmutation | CDK-genmutation | PI3K-genmutation | ROS1 genmutation | KRAS G12C mutationForenede Stater
-
Wuxi People's HospitalRekruttering
-
Second Affiliated Hospital, School of Medicine,...RekrutteringRisikofaktorer | Gen polymorfisme | Alvorlig paradentoseKina
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.UkendtSolid tumor | HER-2-genamplifikation | HER2 genmutation | HER-2 Protein OverekspressionKina
-
Tianjin Medical University Second HospitalRekrutteringSolid tumor | FGF-receptorgenmutation | FGF amplifikation | FGF-receptorgenfamilieomlægning | FGF-receptorgentranslokationKina
-
The Affiliated Hospital of Xuzhou Medical UniversityRekrutteringType 2 diabetes mellitus | Genetiske mutationer | Gen-polymorfismer | Modtagelighed, genetiskKina
-
Taiho Oncology, Inc.Aktiv, ikke rekrutterendeAvanceret cholangiocarcinom | FGFR2-genomlægningerForenede Stater, Spanien, Det Forenede Kongerige, Australien, Taiwan, Italien, Frankrig, Korea, Republikken, Belgien, Japan, Thailand, Tyskland, Brasilien, Peru, Portugal, Argentina, Hong Kong, Mexico, Holland, Polen
-
Second Affiliated Hospital of Guangzhou Medical...Sun Yat-sen University; The First Affiliated Hospital of Guangzhou Medical...RekrutteringKræft | Lungekræft | Genproduktsekvensvariation | Gene abnormitetKina
-
SUNHO（China）BioPharmaceutical CO., Ltd.Rekruttering
-
Xiangya Hospital of Central South UniversityAfsluttetLægemiddelreaktion | Hæmodynamisk rebound | Gene | BedøvelsesmiddelKina
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.UkendtBrystkræft Metastatisk | BRCA 1 genmutation | BRCA 2 genmutationKina
-
Peking University Third HospitalRekrutteringKorsbåndsbrud | Menisk skade | Gene abnormitetKina
-
Yi HanQianfoshan HospitalRekrutteringNyreinsufficiens | Gen polymorfisme | EdoxabanKina
-
Henan Cancer HospitalRekrutteringLymfom | Gene abnormitetKina
-
The First Hospital of Jilin UniversityRekruttering
-
XuanwuH 2University of CologneRekrutteringAlzheimers sygdom | Subjektiv kognitiv tilbagegang | Neuroimaging | GeneKina
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.Aktiv, ikke rekrutterendeBrystkræft Metastatisk | BRCA 1 genmutation | BRCA 2 genmutationItalien, Spanien, Forenede Stater, Tjekkiet, Rumænien, Frankrig, Korea, Republikken, Det Forenede Kongerige, Ungarn, Japan, Peru, Polen, Den Russiske Føderation, Kalkun, Kina, Taiwan, Bulgarien, Schweiz, Mexico
-
Second Xiangya Hospital of Central South UniversityThe First Affiliated Hospital of Nanchang University; Xiangya Hospital... og andre samarbejdspartnereRekrutteringLungekræft, ikke-småcellet | Cirkulerende tumor-DNA | EGFR-genmutation | EGFR-TKI resistent mutation | Primær modstandKina
-
Sun Yat-sen UniversityRekrutteringIkke-småcellet lungekræft (NSCLC) | EGFR-TKI resistent mutation | EGFR-TKI Sensibiliserende mutation | Somatisk mutation | KimlinjemutationerKina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySun Yat-sen UniversityRekrutteringKræft i bugspytkirtlen | Farmakokinetik | Gen-polymorfismerKina
-
Beijing Tongren HospitalUkendtNeuromyelitis Optica | Glukokortikoid resistens | GeneKina
-
Affiliated Hospital to Academy of Military Medical...RekrutteringEndoskopi | Mitokondriel DNA-mutationKina
-
Peking University Third HospitalRekruttering
-
Shengjing HospitalIkke rekrutterer endnuPostoperativt delirium | Generel anæstesi | Døgnrytmeforstyrrelser | Eksosomer | Ur GeneKina
-
Jiangsu vcare pharmaceutical technology co., LTDAfsluttetLokalt avanceret eller metastatisk solid tumor, der rummer en NTRK-genfusionKina
-
Peking Union Medical CollegeUkendtBrystkræft | HER2 genmutationKina
-
Second Affiliated Hospital of Wenzhou Medical UniversityRekrutteringInflammatorisk tarmsygdom | Gene abnormitet | KinesiskKina
-
Beijing Tiantan HospitalBeijing Municipal Science & Technology CommissionAfsluttetForbigående iskæmisk angreb | Slagtilfælde, Akut | Enkelt-gen lidelserKina
-
Guangdong Provincial People's HospitalShanghai Junshi Bioscience Co., Ltd.RekrutteringIkke-småcellet lungekræft | BRAF V600 Mutation | MET Amplifikation | MET Exon 14 Skipping Mutation | RET driver mutation | Erb-B2-receptortyrosinkinase Exon 20-mutationKina
-
Boehringer IngelheimAfsluttet
-
Ascletis Pharmaceuticals Co., Ltd.RekrutteringHIV-infektioner | HIV-1-infektion | PD-L1 genmutationKina
-
Ruijin HospitalRekrutteringP53 Mutation | Myeloid malignitet | MDS | AmlKina
-
Hubei Biological Medicine Industrial Technology...UkendtAvancerede solide tumorer | HRD | BRCA mutationKina
-
Henan Cancer HospitalRekrutteringDiffust storcellet B-celle lymfom | CD79A genmutation | CD79B genmutationKina
-
AnHeart Therapeutics Inc.RekrutteringCholangiocarcinom med IDH1-mutation | Solide tumorer med IDH1-mutationKina
-
Fudan UniversityPeking University First Hospital; Xiangya Hospital of Central South University og andre samarbejdspartnereUkendtGenmutation | Epilepsi idiopatisk | Klinisk sygdom og/eller syndromKina
-
Ying LinRekrutteringHer-2 negative brystkræft | HRR-genmutationKina
-
BeBetter Med IncXiangya Hospital of Central South UniversityRekrutteringAvanceret eller metastatisk solid tumor | KRAS G12C mutationKina
-
Beijing Tongren HospitalAfsluttetMyasthenia Gravis, okulær | Gen polymorfismeKina
-
Nanfang Hospital of Southern Medical UniversitySun Yat-Sen Memorial Hospital of Sun Yat-Sen University; First People's... og andre samarbejdspartnereAfsluttetRefraktær akut myeloid leukæmi | Recidiverende akut myeloid leukæmi | Gene abnormitet | Cytogenetisk abnormitetKina
-
RenJi HospitalPeking University First Hospital; Shanghai Zhongshan Hospital; First Affiliated... og andre samarbejdspartnereRekrutteringNyrekræft | Nyrecellekarcinom | ALK-genmutation | MET-genmutation | HLRCC | Nyretumorhistologi | Kutan leiomyom | BAP1 Tumor Predisposition Syndrome | VHL syndrom | Birt-Hogg-Dube syndrom | Familiær nyrekræft | FLCN-genmutation | FH-genmutation | Kutan Leiomyomata Med Uterine LeiomyomataKina
-
Qilu Hospital of Shandong UniversityTilmelding efter invitationCopeptin | Prognose | Myokardieinfarkt med ikke-obstruktive kranspulsårer | Vækststimuleringsudtrykt gen 2 | IdentifikationKina